PharmVar GeneFocus: CYP3A5

dc.contributor.authorRodriguez-Antona, Cristina
dc.contributor.authorSavieo, Jessica L.
dc.contributor.authorLauschke, Volker M.
dc.contributor.authorSangkuhl, Katrin
dc.contributor.authorDrögemöller, Britt I.
dc.contributor.authorWang, Danxin
dc.contributor.authorvan Schaik, Ron H. N.
dc.contributor.authorGilep, Andrei A.
dc.contributor.authorPeter, Arul P.
dc.contributor.authorBoone, Erin C.
dc.contributor.authorRamey, Bronwyn E.
dc.contributor.authorKlein, Teri E.
dc.contributor.authorWhirl-Carrillo, Michelle
dc.contributor.authorPratt, Victoria M.
dc.contributor.authorGaedigk, Andrea
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-05-15T21:22:56Z
dc.date.available2024-05-15T21:22:56Z
dc.date.issued2022-12
dc.description.abstractThe Pharmacogene Variation Consortium (PharmVar) catalogs star (*) allele nomenclature for the polymorphic human CYP3A5 gene. Genetic variation within the CYP3A5 gene locus impacts the metabolism of several clinically important drugs, including the immunosuppressants tacrolimus, sirolimus, cyclosporine, and the benzodiazepine midazolam. Variable CYP3A5 activity is of clinical importance regarding tacrolimus metabolism. This GeneFocus provides a CYP3A5 gene summary with a focus on aspects regarding standardized nomenclature. In addition, this review also summarizes recent changes and updates including the retirement of several allelic variants and provides an overview of how PharmVar CYP3A5 star allele nomenclature is utilized by the Pharmacogenomics Knowledgebase (PharmGKB) and the Clinical Pharmacogenetics Implementation Consortium (CPIC).
dc.eprint.versionAuthor's manuscript
dc.identifier.citationRodriguez-Antona, C., Savieo, J. L., Lauschke, V. M., Sangkuhl, K., Drögemöller, B. I., Wang, D., van Schaik, R. H. N., Gilep, A. A., Peter, A. P., Boone, E. C., Ramey, B. E., Klein, T. E., Whirl-Carrillo, M., Pratt, V. M., & Gaedigk, A. (2022). PharmVar GeneFocus: CYP3A5. Clinical Pharmacology & Therapeutics, 112(6), 1159–1171. https://doi.org/10.1002/cpt.2563
dc.identifier.urihttps://hdl.handle.net/1805/40785
dc.language.isoen_US
dc.publisherASCPT
dc.relation.isversionof10.1002/cpt.2563
dc.relation.journalClinical Pharmacology and Therapeutics
dc.rightsPublisher Policy
dc.sourceAuthor
dc.subjectPharmacogene Variation Consortium (PharmVar)
dc.subjectCYP3A5 gene
dc.subjectPolymorphic
dc.subjectCatalog
dc.titlePharmVar GeneFocus: CYP3A5
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Rodriguez-Antona2022PharmVar-AAM.pdf
Size:
1.07 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: